Study of Hemospray for Lower Gastrointestinal Hemorrhage

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

November 6, 2016

Study Completion Date

November 6, 2016

Conditions
Colonic DiverticulaAngiodysplasiaColonic Polyp
Interventions
DEVICE

Hemospray

The Hemospray™ device comes in a 7F kit and a 10F kit. Each kit includes two 220 cm Teflon application catheters, a handle with CO2 cartridge and a syringe containing approximately 20 g of the Hemospray™ material. Hemospray™ is a proprietary inorganic mineral powder that acts as a mechanical barrier when sprayed over a bleeding lesion and the surrounding mucosa.

Trial Locations (4)

Unknown

Royal Alexandra Hospital, Edmonton

University of Alberta Hospital, Edmonton

Hotel Dieu Hospital, Kingston

Montreal General Hospital - McGill University, Montreal

All Listed Sponsors
lead

Cook Group Incorporated

INDUSTRY

NCT02099435 - Study of Hemospray for Lower Gastrointestinal Hemorrhage | Biotech Hunter | Biotech Hunter